2,5-Bis(bromomethyl)-1-methoxy-4-(3′,7′-dimethyloctyloxy)benzene

Catalog No. :
ACFWAL614
CAS No. :
287919-00-0
Molecular Formula :
C19H30Br2O2
Molecular Weight :
450.26

IUPAC Name:1,4-bis(bromomethyl)-2-((3,7-dimethyloctyl)oxy)-5-methoxybenzene

2,5-Bis(bromomethyl)-1-methoxy-4-(3′,7′-dimethyloctyloxy)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,5-Bis(bromomethyl)-1-methoxy-4-(3′,7′-dimethyloctyloxy)benzene
IUPAC Name1,4-bis(bromomethyl)-2-((3,7-dimethyloctyl)oxy)-5-methoxybenzene
Molecular FormulaC19H30Br2O2
Molecular Weight450.26
SMILESCC(C)CCCC(C)CCOC1=C(CBr)C=C(OC)C(CBr)=C1
InChI KeyDOKSAXJBKYCNRE-UHFFFAOYSA-N
Synonym287919-00-0 | 1,4-bis(bromomethyl)-2-(3,7-dimethyloctoxy)-5-methoxybenzene | 2 5-BIS(BROMOMETHYL)-1-METHOXY-4-(3'-7'& | 2,5-Bis(bromomethyl)-1-methoxy-4-(3 inverted exclamation marka,7 inverted exclamation marka-dimethyloctyloxy)benzene | 2 5-BIS(BROMOMETHYL)-1-M
CAS No.287919-00-0
PubChem CID4145218

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H290-H314
Precautionary Statement(s)
P234-P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340+P310-P305+P351+P338+P310-P363-P390-P405-P406-P501

Synthetic Route by SureRoute

1. ACFWAL614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFWAL614 route product structure diagram
    ACFWAL614287919-00-0
Inquiry

2. ACFWAL614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFWAL614 route product structure diagram
    ACFWAL614287919-00-0
Inquiry

Comments (0)